ES527776A0 - Procedimiento de preparacion de derivados de 1,4-dihidropiridinas. - Google Patents
Procedimiento de preparacion de derivados de 1,4-dihidropiridinas.Info
- Publication number
- ES527776A0 ES527776A0 ES527776A ES527776A ES527776A0 ES 527776 A0 ES527776 A0 ES 527776A0 ES 527776 A ES527776 A ES 527776A ES 527776 A ES527776 A ES 527776A ES 527776 A0 ES527776 A0 ES 527776A0
- Authority
- ES
- Spain
- Prior art keywords
- dihidropiridinas
- derivatives
- procedure
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH685882 | 1982-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8706633A1 ES8706633A1 (es) | 1987-07-16 |
ES527776A0 true ES527776A0 (es) | 1987-07-16 |
Family
ID=4316137
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES527776A Expired ES8706633A1 (es) | 1982-11-24 | 1983-11-24 | Procedimiento de preparacion de derivados de 1,4-dihidropiridinas. |
ES543652A Expired ES8604147A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos |
ES543653A Expired ES8703139A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de preparar derivados de 1,4-dihidropiridinas |
ES543655A Expired ES8603700A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de preparar compuestos 1,4-dihidropiridinicos |
ES543654A Expired ES8603699A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de obtener derivados de 1,4-dihidropiridinas |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES543652A Expired ES8604147A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de obtencion de derivados 1,4-dihidropiridini-cos |
ES543653A Expired ES8703139A1 (es) | 1982-11-24 | 1985-05-30 | Procedimiento de preparar derivados de 1,4-dihidropiridinas |
ES543655A Expired ES8603700A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de preparar compuestos 1,4-dihidropiridinicos |
ES543654A Expired ES8603699A1 (es) | 1982-11-24 | 1985-05-30 | Metodo de obtener derivados de 1,4-dihidropiridinas |
Country Status (8)
Country | Link |
---|---|
US (2) | US4656181A (es) |
EP (1) | EP0126094B1 (es) |
JP (1) | JPS60500255A (es) |
CA (1) | CA1256872A (es) |
DE (1) | DE3381680D1 (es) |
ES (5) | ES8706633A1 (es) |
IT (1) | IT1167269B (es) |
WO (1) | WO1984002132A1 (es) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4603135A (en) * | 1983-10-17 | 1986-07-29 | Takeda Chemical Industries, Ltd. | Substituted piperazinyl alkyl esters of 2-amino-4-aryl-1,4-dihydro-6-alkyl-3,5-pyridinedicarboxylates |
US5137889A (en) * | 1983-12-02 | 1992-08-11 | Otsuka Pharmaceutical Co., Ltd. | Dihydropyridine derivatives and process for preparing the same |
JPS60120861A (ja) * | 1983-12-02 | 1985-06-28 | Otsuka Pharmaceut Co Ltd | ジヒドロピリジン誘導体 |
IE57810B1 (en) * | 1984-03-27 | 1993-04-21 | Delagrange Lab | 1,4-dihydropyridine derivatives,their preparation and their use |
GB2162513B (en) * | 1984-06-25 | 1988-01-20 | Toyama Chemical Co Ltd | Dihydropyridine derivatives |
JPS6147477A (ja) * | 1984-08-14 | 1986-03-07 | Kowa Co | 新規1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体 |
FI853478L (fi) * | 1984-09-14 | 1986-03-15 | Ciba Geigy Ag | Foerfarande foer framstaellning av fenylalkylfoereningar. |
US4975440A (en) * | 1984-09-28 | 1990-12-04 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Optically-active 1,4-dihydropyridine |
GB8428552D0 (en) * | 1984-11-12 | 1984-12-19 | Sandoz Ltd | Organic compounds |
US4757071A (en) * | 1984-12-14 | 1988-07-12 | Nisshin Flour Milling Co., Ltd. | 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases |
JPH0676405B2 (ja) * | 1986-06-13 | 1994-09-28 | 日清製粉株式会社 | 1,4―ジヒドロピリジン誘導体およびそれを含有する医薬組成物 |
IL77843A (en) * | 1985-02-11 | 1989-07-31 | Syntex Inc | Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them |
JPS61227567A (ja) * | 1985-04-01 | 1986-10-09 | Eisai Co Ltd | 1,4−ジヒドロピリジン誘導体 |
EP0222702A3 (de) * | 1985-11-06 | 1988-01-07 | Ciba-Geigy Ag | Basische Carbonylverbindungen |
DE3600594A1 (de) * | 1986-01-11 | 1987-07-16 | Bayer Ag | Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung |
DE3601397A1 (de) * | 1986-01-18 | 1987-07-23 | Bayer Ag | Substituierte 1,4-dihydropyridin-3-carbonsaeurepiperazide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
DK114587A (da) * | 1986-03-12 | 1987-09-13 | Byk Gulden Lomberg Chem Fab | Monocycliske esterderivater |
DE3617976A1 (de) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten |
US4761420A (en) * | 1986-06-13 | 1988-08-02 | Laboratoires Syntex S.A. | Antihypertensive dihydropyridine derivatives |
US4886819A (en) * | 1986-08-27 | 1989-12-12 | The Green Cross Corporation | Dihydropyridine derivatives and pharmaceutical composition thereof |
JPH0688973B2 (ja) * | 1987-03-12 | 1994-11-09 | 京都薬品工業株式会社 | 1,4−ジヒドロピリジン誘導体 |
US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
DE69330130T2 (de) * | 1992-08-31 | 2001-08-02 | Mercian Corp | Verfahren zur herstellung von optisch aktiven 1,4-dihydropyridinen |
DE4233347A1 (de) * | 1992-10-05 | 1994-04-07 | Bayer Ag | Dihydropyridin-alkoxy- und -alkylamino-aroylester |
US6001857A (en) * | 1992-10-30 | 1999-12-14 | Bayer Aktiengesellschaft | Heterocyclyl substituted dihydropyridines |
ES2096179T3 (es) * | 1992-10-30 | 1997-03-01 | Bayer Ag | Dihidropiridinas sustituidas en la posicion 4 con un heterociclilfenilo. |
DE4236707A1 (de) * | 1992-10-30 | 1994-05-05 | Bayer Ag | 4-Heterocyclyl substituierte Dihydropyridine |
DE4342193A1 (de) * | 1993-12-10 | 1995-06-14 | Bayer Ag | Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester |
JP3407888B2 (ja) * | 1994-08-29 | 2003-05-19 | メルシャン株式会社 | 1,4−ジヒドロピリジン誘導体 |
JP2002534363A (ja) * | 1999-01-08 | 2002-10-15 | エミスフェアー・テクノロジーズ・インク | ポリマー性デリバリー剤及びデリバリー剤化合物 |
ES2287110T3 (es) * | 2000-04-11 | 2007-12-16 | Sankyo Company, Limited | Composicion farmaceutica estabilizada que contiene un bloqueador de calcio consistente en azelnidipina. |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
JP6473133B2 (ja) * | 2013-03-15 | 2019-02-20 | アラクセス ファーマ エルエルシー | Krasg12cの共有結合性阻害剤 |
JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
CN105669532B (zh) * | 2014-12-03 | 2018-11-02 | 广州市恒诺康医药科技有限公司 | 尼莫地平水溶性衍生物及其制备方法和应用 |
JP2018513853A (ja) | 2015-04-10 | 2018-05-31 | アラクセス ファーマ エルエルシー | 置換キナゾリン化合物およびその使用方法 |
MX2017013275A (es) | 2015-04-15 | 2018-01-26 | Araxes Pharma Llc | Inhibidores triciclicos fusionados de kras y metodos de uso de los mismos. |
US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
WO2017058902A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
EP3356354A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
WO2017058768A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
EP3356349A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
EP3356347A1 (en) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
WO2017058728A1 (en) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibitors of kras g12c mutant proteins |
EP3356359B1 (en) | 2015-09-28 | 2021-10-20 | Araxes Pharma LLC | Inhibitors of kras g12c mutant proteins |
EA038635B9 (ru) | 2015-11-16 | 2021-10-26 | Араксис Фарма Ллк | 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения |
US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
CN110036010A (zh) | 2016-09-29 | 2019-07-19 | 亚瑞克西斯制药公司 | Kras g12c突变蛋白的抑制剂 |
WO2018068017A1 (en) | 2016-10-07 | 2018-04-12 | Araxes Pharma Llc | Heterocyclic compounds as inhibitors of ras and methods of use thereof |
US11358959B2 (en) | 2017-01-26 | 2022-06-14 | Araxes Pharma Llc | Benzothiophene and benzothiazole compounds and methods of use thereof |
EP3573970A1 (en) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | 1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer |
US11279689B2 (en) | 2017-01-26 | 2022-03-22 | Araxes Pharma Llc | 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer |
CN110382482A (zh) | 2017-01-26 | 2019-10-25 | 亚瑞克西斯制药公司 | 稠合的杂-杂二环化合物及其使用方法 |
WO2018140512A1 (en) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Fused bicyclic benzoheteroaromatic compounds and methods of use thereof |
CN110831933A (zh) | 2017-05-25 | 2020-02-21 | 亚瑞克西斯制药公司 | 喹唑啉衍生物作为突变kras、hras或nras的调节剂 |
BR112019024674A2 (pt) | 2017-05-25 | 2020-06-16 | Araxes Pharma Llc | Inibidores covalentes da kras |
JP2020521741A (ja) | 2017-05-25 | 2020-07-27 | アラクセス ファーマ エルエルシー | がんの処置のための化合物およびその使用の方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670824C3 (de) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-33-dicarbonsäurealkylester |
DE2117571C3 (de) * | 1971-04-10 | 1979-10-11 | Bayer Ag, 5090 Leverkusen | Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
DE2117573C3 (de) * | 1971-04-10 | 1978-07-27 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel |
US3996234A (en) * | 1972-04-18 | 1976-12-07 | Bayer Aktiengesellschaft | 1,4-Dihydropyridine carboxylic acid esters |
DE2218644C3 (de) * | 1972-04-18 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel |
DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
FR2405937A1 (fr) * | 1977-10-14 | 1979-05-11 | Labaz | Nouveaux derives de dihydropyridine, leur procede de preparation et leur application |
SE429652B (sv) * | 1978-06-30 | 1983-09-19 | Haessle Ab | 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester |
DE2847236A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
US4258042A (en) * | 1980-04-11 | 1981-03-24 | Usv Pharmaceutical Corporation | Antihypertensive pyridines and compositions |
DE3042769A1 (de) * | 1980-11-13 | 1982-06-09 | Bayer Ag, 5090 Leverkusen | C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
-
1982
- 1982-11-18 US US06/637,216 patent/US4656181A/en not_active Expired - Lifetime
-
1983
- 1983-11-18 WO PCT/CH1983/000128 patent/WO1984002132A1/de active IP Right Grant
- 1983-11-18 JP JP58503515A patent/JPS60500255A/ja active Granted
- 1983-11-18 EP EP83903371A patent/EP0126094B1/fr not_active Expired - Lifetime
- 1983-11-18 DE DE8383903371T patent/DE3381680D1/de not_active Expired - Lifetime
- 1983-11-23 CA CA000441800A patent/CA1256872A/fr not_active Expired
- 1983-11-23 IT IT23841/83A patent/IT1167269B/it active
- 1983-11-24 ES ES527776A patent/ES8706633A1/es not_active Expired
-
1985
- 1985-05-30 ES ES543652A patent/ES8604147A1/es not_active Expired
- 1985-05-30 ES ES543653A patent/ES8703139A1/es not_active Expired
- 1985-05-30 ES ES543655A patent/ES8603700A1/es not_active Expired
- 1985-05-30 ES ES543654A patent/ES8603699A1/es not_active Expired
-
1986
- 1986-06-30 US US06/880,148 patent/US4727066A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES8703139A1 (es) | 1987-02-16 |
WO1984002132A1 (en) | 1984-06-07 |
IT1167269B (it) | 1987-05-13 |
US4656181A (en) | 1987-04-07 |
EP0126094B1 (fr) | 1990-06-20 |
CA1256872A (fr) | 1989-07-04 |
JPH0559906B2 (es) | 1993-09-01 |
ES543653A0 (es) | 1987-02-16 |
JPS60500255A (ja) | 1985-02-28 |
ES8603699A1 (es) | 1986-01-16 |
ES543652A0 (es) | 1986-01-16 |
IT8323841A0 (it) | 1983-11-23 |
ES8706633A1 (es) | 1987-07-16 |
US4727066A (en) | 1988-02-23 |
ES543654A0 (es) | 1986-01-16 |
DE3381680D1 (de) | 1990-07-26 |
ES543655A0 (es) | 1986-01-16 |
ES8604147A1 (es) | 1986-01-16 |
ES8603700A1 (es) | 1986-01-16 |
EP0126094A1 (fr) | 1984-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES527776A0 (es) | Procedimiento de preparacion de derivados de 1,4-dihidropiridinas. | |
ES499299A0 (es) | Procedimiento de preparacion de derivados de la trimetoxi- 3,4,5 cinamoilpiperacina | |
ES511220A0 (es) | "procedimiento de preparacion de nuevos derivados 4-aminoetoxi-5-isopropil-2-metil". | |
ES510730A0 (es) | "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo". | |
ES533618A0 (es) | Procedimiento de preparacion de nuevos derivados de guarnina. | |
ES519702A0 (es) | Procedimiento para la preparacion de 1,1-dioxidos de 3-amidino-benzoisotiazol. | |
ES513974A0 (es) | Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol. | |
ES518033A0 (es) | Procedimiento para la preparacion de (-)-2-1-(2,6-diclorofenoxi)-etil-1,3-diazaciclopent-2-eno. | |
ES508293A0 (es) | "procedimiento para la preparacion de derivados de tiazolina". | |
ES509761A0 (es) | "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas". | |
MX7052E (es) | Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas | |
NO162018C (no) | Fremgangsmaate for fremstilling av 4-metyl-5-alkyltiometylimidazoler. | |
ES520537A0 (es) | Procedimiento para la preparacion de derivados de carbaciclina. | |
ES517428A0 (es) | Procedimiento de preparacion de derivados bencilidenicos. | |
ES510963A0 (es) | Procedimiento de preparacion de alcoxiaminohidridosilanos. | |
ES522653A0 (es) | Procedimiento de preparacion de derivados de piperacina. | |
ES520201A0 (es) | Procedimiento para la obtencion de derivados de 1,4-dihidropiridina. | |
ES520847A0 (es) | Procedimiento para la preparacion de 1,2,4-triazol-1-il-propionitrilos. | |
ES514224A0 (es) | "procedimiento para la preparacion de 2,4-diamino-(3,5-dimetoxi-4-metoxietoxibenzil)-pirimidina". | |
MX159206A (es) | Procedimiento para preparar derivados de 20,21 dinoreburnamenina | |
IT8421695A0 (it) | Procedimento per la preparazione di 3, 11-dimetil-2-nonacosanone. | |
ES516069A0 (es) | "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea". | |
ES507317A0 (es) | Procedimiento para la preparacion de derivados de la hexahi-dro-2,3,3,4,5.6-1h-indol(3,2,1-de)(naftiridina-1,5) | |
ES516225A0 (es) | "procedimiento para la preparacion de derivados de bis-aminometil-antraquinona". | |
ES520986A0 (es) | Procedimiento para la preparacion de derivados de 2-piridona. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 20041102 |